Nu Skin Enterprises (NUS) Trading Down 13.7% After Earnings Miss

Nu Skin Enterprises, Inc. (NYSE:NUS) shares were down 13.7% during trading on Thursday following a dissappointing earnings announcement. The stock traded as low as $61.85 and last traded at $62.84. Approximately 986,430 shares were traded during mid-day trading, an increase of 113% from the average daily volume of 463,262 shares. The stock had previously closed at $72.82.

The company reported $0.94 earnings per share for the quarter, missing the consensus estimate of $0.96 by ($0.02). Nu Skin Enterprises had a net margin of 5.74% and a return on equity of 25.67%. The company had revenue of $675.31 million for the quarter, compared to analysts’ expectations of $664.99 million. During the same period in the previous year, the firm earned $0.76 earnings per share. The firm’s revenue for the quarter was up 19.8% on a year-over-year basis.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Friday, November 30th will be issued a dividend of $0.365 per share. The ex-dividend date is Thursday, November 29th. This represents a $1.46 annualized dividend and a dividend yield of 2.32%. Nu Skin Enterprises’s payout ratio is 45.20%.

Several research analysts have recently weighed in on NUS shares. Zacks Investment Research cut shares of Nu Skin Enterprises from a “strong-buy” rating to a “hold” rating in a report on Monday, October 8th. DA Davidson started coverage on shares of Nu Skin Enterprises in a report on Tuesday, October 9th. They set a “buy” rating and a $92.00 price objective for the company. Jefferies Financial Group reissued a “buy” rating and set a $98.00 price objective on shares of Nu Skin Enterprises in a report on Tuesday, September 4th. Stifel Nicolaus raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and boosted their price objective for the company from $57.00 to $70.00 in a report on Thursday, August 2nd. They noted that the move was a valuation call. Finally, Citigroup set a $88.00 price objective on shares of Nu Skin Enterprises and gave the company a “buy” rating in a report on Thursday. One research analyst has rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating to the stock. Nu Skin Enterprises presently has an average rating of “Buy” and an average target price of $86.29.

In related news, General Counsel D Matthew Dorny sold 2,500 shares of the business’s stock in a transaction that occurred on Tuesday, September 4th. The shares were sold at an average price of $79.90, for a total transaction of $199,750.00. Following the completion of the sale, the general counsel now directly owns 33,871 shares in the company, valued at $2,706,292.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 5.20% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in NUS. Harvest Fund Management Co. Ltd grew its position in Nu Skin Enterprises by 162.9% during the third quarter. Harvest Fund Management Co. Ltd now owns 1,291 shares of the company’s stock valued at $106,000 after buying an additional 800 shares during the period. Global X Management Co LLC grew its position in Nu Skin Enterprises by 141.9% during the second quarter. Global X Management Co LLC now owns 1,732 shares of the company’s stock valued at $135,000 after buying an additional 1,016 shares during the period. First Hawaiian Bank bought a new stake in Nu Skin Enterprises during the third quarter valued at approximately $165,000. Ffcm LLC grew its position in Nu Skin Enterprises by 181.9% during the third quarter. Ffcm LLC now owns 1,911 shares of the company’s stock valued at $177,000 after buying an additional 1,233 shares during the period. Finally, Engineers Gate Manager LP bought a new stake in Nu Skin Enterprises during the third quarter valued at approximately $204,000. Institutional investors own 76.47% of the company’s stock.

The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.19 and a current ratio of 1.82. The stock has a market cap of $4.04 billion, a PE ratio of 19.46, a P/E/G ratio of 1.78 and a beta of 1.04.

ILLEGAL ACTIVITY NOTICE: This article was first reported by WKRB News and is the sole property of of WKRB News. If you are reading this article on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.wkrb13.com/2018/11/09/nu-skin-enterprises-nus-trading-down-13-7-after-earnings-miss.html.

About Nu Skin Enterprises (NYSE:NUS)

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.

Read More: What is the Ex-Dividend Date in Investing?

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply